Financial statements Captor Therapeutics
Cash flow statement of Captor Therapeutics
Company age:
Age:
6 y. 10 m. 27 d.
Share capital:
Share capital:
359 000 PLN
Cash inflows of CAPTOR THERAPEUTICS
|
Year
|
2018
|
2019
|
|---|---|---|
| Net cash from operating expenses | -4 341 937,67 | 1 341 902,13 |
| Net cash flow from investing activities | -175 749,26 | -157 822,93 |
| Net cash flow from financial activities | 5 330 953,86 | 8 712 961,82 |
| Total net cash flow | 813 266,93 | 9 897 041,02 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.